Conjunctivitis, Allergic: all 231 studies

Page 1 of 3. Open to participants first (19), then studies with results posted, then the rest; newest registration first within each.

• Daydrop® Triple Action for Allergic Eye SymptomsRecruitingNCT07805759Not applicable
• Investigating Nasal and Ocular Immune Response to Conjunctival Allergen ExposureRecruitingNCT07801625
• Treatment of Ocular Surface InflammationsRecruitingNCT07732855
• A Study to Identify and Characterize Adults and Pediatric Participants With Cat and/or Birch AllergyNot yet recruitingNCT07710846
• A Study to Evaluate the Efficacy and Safety of Fel d 1 Monoclonal Antibodies in Adult and Pediatric Participants With Allergic Conjunctivitis Due to Cat AllergyRecruitingNCT07675811Phase 3
• An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCEDRecruitingNCT07519902Phase 3
• Evaluation of TL-925 for the Treatment of Seasonal Allergic ConjunctivitisRecruitingNCT07220408Phase 2
• Treg Effector Function and Th2/Treg Ratio in Allergic Conjunctivitis: Effect of Desensitization TherapyNot yet recruitingNCT07171307
• A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal KeratoconjunctivitisRecruitingNCT07169695Phase 2
• Tacrolimus Eye Drops in Treatment of Vernal KeratoconjunctivitisNot yet recruitingNCT07138742Not applicable
• 3% Diquafosol Ophthalmic Solution for Active Moderate-to-Severe Vernal KeratoconjunctivitisRecruitingNCT06903884Phase 3
• Efficacy and Safety of Oral Probiotics on Ocular Symptoms and Gut Microbiome of Children with Vernal KeratoconjunctivitisNot yet recruitingNCT06793514Phase 1
• Evaluation of the Efficacy of Allergen-specific Immunotherapy Using Assessment in an Allergen Exposure Chamber-a Randomized Placebo-controlled Double-blind StudyRecruitingNCT06778213Phase 4
• Corneal Topography in Vernal KeratoconjunctivitisNot yet recruitingNCT06746467
• Evaluation of TL-925 for the Treatment of Allergic ConjunctivitisRecruitingNCT06686472Phase 2
• Factors Determining Tolerance to Nasal Allergen Exposure With Advanced Age in a Subset of Birch Pollen Allergic SubjectsNot yet recruitingNCT06459219
• A Study of TL-925 for the Treatment of Allergic ConjunctivitisRecruitingNCT06153342Phase 2
• The Role of Vitamin D in Corneal Epithelial Barrier Function, Ocular Microbiome, Ocular Inflammation, and Visual Acuity of Children With Allergic ConjunctivitisEnrolling by invitationNCT05839938Not applicable
• Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular SurfaceRecruitingNCT04198740
• Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic SolutionCompletedNCT05815758Phase 3Results posted
• Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic ConjunctivitisCompletedNCT05579730Phase 3Results posted
• The INVIGORATE 2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic ConjunctivitisCompletedNCT05234554Phase 3Results posted
• Safety and Efficacy of VSJ-110 in the Treatment of Allergic Conjunctivitis in Adults With a History of Ocular AllergiesCompletedNCT04622345Phase 2Results posted
• The INVIGORATE Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis.CompletedNCT04207736Phase 3Results posted
• A Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Allergic ConjunctivitisCompletedNCT04050865Phase 3Results posted
• Topical rVA576 for Treatment of Atopic KeratoconjunctivitisTerminatedNCT04037891Phase 1/2Results posted
• A Methodology Development Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Using the Environmental Exposure ChamberCompletedNCT03709121Phase 1/2Results posted
• Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy StudyCompletedNCT03682965Phase 2Results posted
• A Methodology Development Environmental Clinical Trial of Reproxalap in Subjects With Seasonal Allergic ConjunctivitisCompletedNCT03660878Phase 1/2Results posted
• ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic ConjunctivitisCompletedNCT03494504Phase 3Results posted
• A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and VehicleCompletedNCT03489941Phase 3Results posted
• A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model.CompletedNCT03479307Phase 3Results posted
• Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic ConjunctivitisCompletedNCT03320434Phase 2Results posted
• A Single-Center, Phase 2 Study Evaluating Bilastine Ophthalmic Solution in the CAC® ModelCompletedNCT03231969Phase 2Results posted
• A Study of ADX-102 in Subjects With Allergic ConjunctivitisCompletedNCT03012165Phase 2Results posted
• OTX-15-002: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic ConjunctivitisCompletedNCT02988882Phase 3Results posted
• Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic ConjunctivitisCompletedNCT02978183Phase 2Results posted
• Efficacy of Co-administration of Bilastine and Montelukast in Patients With SARC and AsthmaCompletedNCT02761252Phase 4Results posted
• A Safety and Activity Study of NS2 in Subjects With Allergic ConjunctivitisCompletedNCT02578914Phase 2Results posted
• OTX-14-007: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic ConjunctivitisCompletedNCT02445326Phase 3Results posted
• Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese SubjectsCompletedNCT02322216Phase 3Results posted
• A Single-Center Evaluation of the Anti-Inflammatory Effects of Lastacaft as Measured by In-Vivo Confocal MicroscopyCompletedNCT02308501Phase 4Results posted
• Effectiveness of Olopatadine HCl Ophthalmic Solution for the Treatment of Allergic Conjunctivitis in JapanCompletedNCT02251613Phase 4Results posted
• AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic ConjunctivitisCompletedNCT02161146Phase 3Results posted
• A Multi-Center Study Evaluating the Safety of AC-170 0.24%CompletedNCT02132169Phase 3Results posted
• AGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic ConjunctivitisCompletedNCT02082262Phase 3Results posted
• Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic ConjunctivitisCompletedNCT02079649Phase 2Results posted
• OTX-14-001: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic ConjunctivitisCompletedNCT02062905Phase 2Results posted
• Safety and Efficacy of Relestat Ophthalmic Solution 0.05% for Allergic Conjunctivitis in KoreaCompletedNCT01987765Results posted
• A Multi-Center, Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to VehicleCompletedNCT01881113Phase 3Results posted
• AGN-229666 for the Treatment of Allergic ConjunctivitisCompletedNCT01754766Phase 2Results posted
• Double-Masked Trial of NOVA22007 (1mg/mL Ciclosporin/Cyclosporine) Versus Vehicle in Pediatric Patients With Active Severe Vernal KeratoconjunctivitisCompletedNCT01751126Phase 3Results posted
• Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic ConjunctivitisCompletedNCT01743027Phase 3Results posted
• A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic ConjunctivitisCompletedNCT01732757Phase 4Results posted
• Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge ModelCompletedNCT01730872Phase 4Results posted
• A Six-Week Safety Study of an Investigational Ophthalmic SolutionCompletedNCT01698814Phase 3Results posted
• Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis PatientsCompletedNCT01697969Phase 4Results posted
• A Single-Center,Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to VehicleCompletedNCT01685242Phase 3Results posted
• Non-Pharmaceutical Treatment of Seasonal Allergic ConjunctivitisCompletedNCT01569191Phase 4Results posted
• A Multi-Center Study Evaluating the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle in the Conjunctival Allergen Challenge (CAC)CompletedNCT01551056Phase 3Results posted
• A Survey of Adults and Children With Allergic Rhinoconjunctivitis (MK-7243-021)CompletedNCT01535118Results posted
• Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) ModelCompletedNCT01534195Phase 4Results posted
• Subcutaneous Immunotherapy in Patients Sensitized to Dermatophagoides Pteronyssinus (DPT)CompletedNCT01489020Phase 1Results posted
• Efficacy and Safety of AL-4943A Ophthalmic Solution in Patients With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge (CAC) ModelCompletedNCT01479374Phase 3Results posted
• A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic ConjunctivitisCompletedNCT01470118Phase 4Results posted
• Bepreve vs. Alrex in Subjects With Moderate to Severe Allergic ConjunctivitisCompletedNCT01443442Phase 4Results posted
• An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to PlaceboCompletedNCT01439815Phase 4Results posted
• Alrex® Versus Patanol in the Treatment of Seasonal Allergic Conjunctivitis(SAC)CompletedNCT01435460Phase 3Results posted
• A Long-term Study of DE-114 Ophthalmic Solution in Patients With Allergic ConjunctivitisCompletedNCT01363713Phase 3Results posted
• Study of DE-114 Ophthalmic Solution in Patients With Allergic ConjunctivitisCompletedNCT01363700Phase 3Results posted
• The Effect of BEPREVE 1.5% on Tear Film Osmolarity and Tear Film Lipid LayerCompletedNCT01346371Phase 4Results posted
• Efficacy of AC-170 for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge (CAC) ModelCompletedNCT01332188Phase 2/3Results posted
• Effect of Different Concentrations of SPARC1102 on Allergic ConjunctivitisCompletedNCT01320553Phase 2Results posted
• Mapracorat Ophthalmic Formulation in Subjects With Allergic ConjunctivitisCompletedNCT01289431Phase 2Results posted
• Assessment of Alcon's Ocular Image Quantification SystemCompletedNCT01282138Phase 4Results posted
• Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Seasonal Allergic Conjunctivitis PatientsCompletedNCT01174823Phase 2Results posted
• Patient Perceptions and Quality of Life Associated With the Use of Olapatadine 0.2% for the Treatment of Allergic ConjunctivitisCompletedNCT01159769Phase 4Results posted
• Study Evaluating the Safety of KetoNaph Ophthalmic Solution in Healthy VolunteersCompletedNCT01159015Phase 3Results posted
• Efficacy of AC-150 for the Treatment of Allergic Conjunctivitis in the Enviro-CAC™ ModelCompletedNCT01134328Phase 2Results posted
• Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic ConjunctivitisCompletedNCT01119287Phase 4Results posted
• Loteprednol Ophthalmic Base Compared to Loteprednol Ophthalmic Suspension vs Placebo in an Allergen ChallengeCompletedNCT01107405Phase 2Results posted
• Study of the Effect of Fluticasone Furoate Nasal Spray on Spring Allergy Eye SymptomsCompletedNCT00891436Phase 4Results posted
• Safety and Efficacy Study of a Eye Drop for Eye AllergyCompletedNCT00889330Phase 3Results posted
• Safety Study of a Contact Lens With Ketotifen in Healthy, Normal VolunteersCompletedNCT00889252Phase 3Results posted
• Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic KeratoconjunctivitisCompletedNCT00884585Phase 3Results posted
• Efficacy Study to Evaluate the Effectiveness of 3 Concentrations of SAR 1118 in Allergic ConjunctivitisCompletedNCT00882687Phase 2Results posted
• Efficacy Investigation Study of Olopatadine Hydrochloride Ophthalmic Solution Using OHIO Chamber in Patients With Seasonal Allergic Rhinitis (SAR)CompletedNCT00818805Phase 4Results posted
• Olopatadine Eye Drops and Allergy Skin TestingCompletedNCT00775658Not applicableResults posted
• Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Acute Allergic Conjunctivitis.CompletedNCT00770133Phase 3Results posted
• Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis.CompletedNCT00769886Phase 3Results posted
• Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) ModelCompletedNCT00689078Phase 4Results posted
• Effect of Olopatadine on Allergic Tear MediatorsCompletedNCT00609128Not applicableResults posted
• Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic ConjunctivitisCompletedNCT00586664Phase 3Results posted
• Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal VolunteersCompletedNCT00586625Phase 3Results posted
• A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic RhinoconjunctivitisCompletedNCT00574704Phase 2Results posted
• Safety Study of a Contact Lens With Ketotifen in Healthy, Normal VolunteersCompletedNCT00569777Phase 3Results posted
• Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic ConjunctivitisCompletedNCT00534794Phase 4Results posted
• Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic ConjunctivitisCompletedNCT00424398Phase 2/3Results posted
• Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (VKC)CompletedNCT00328653Phase 2/3Results posted
• OJO-miR: microRNA Expression in Allergic Conjunctivitis.Active, not recruitingNCT07385495

← Conjunctivitis, Allergic overview